logo-loader
NASDAQ:AARD

Aardvark Therapeutics Inc.

Receive alerts
Market:
NASDAQ
Price
0.91 USD
Day Change
-20.87%
Market Cap:
$19.92 m
52 weeks high
16.60
52 weeks low
0.91

In brief

Aardvark is a clinical-stage biopharmaceutical company developing novel, small-molecule therapeutics designed to suppress hunger for the treatment of Prader-Willi Syndrome (PWS) and metabolic diseases. Hunger, which is the discomfort from not having eaten recently, is a distinct neural signaling pathway separate from appetite, the reward-seeking desire for food.